| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Caring People Alliance, founded in 1932, is a member of the Boys and Girls Clubs of America and the United Way. It is one of the Philadelphia region's largest human service agencies. Our primary focus is on children and youth and the matters that most
Absolute Home Health Care is a Kissimmee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prognosis Health Information Systems (PROGNOSIS) is the progeny of an eight year old hospital business software vendor and a thirty-five year old medical records service and software provider which have provided products and services to hospitals across America.
Atritech is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.